evostatin eficacy and safety in treatment of squamous carcinoma of head and neck
Phase 2
Recruiting
- Registration Number
- IRCT20171204037739N1
- Lead Sponsor
- Ahvaz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Age more than 18years old
Biopsy confirmed squamous cell carcinoma of head and neck
Exclusion Criteria
Surgical resection of head head and neck mass
Use of Anti inflammatory drug or Asprine more than 3days in week
Use of anti cuaglane drugs, fibrate, cyclosporine, OCP,
Hypersensitivity to Levastatin
Life expectancy shorter than 2years
Received chemotherapy perior chemoradiotherapy
Pregnancy
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method